Intercepting pancreatic cancer with a vaccine
Nature Medicine, Published online: 20 August 2026; doi:10.1038/d41591-026-00041-3 An ‘off-the-shelf’ vaccine that targets mutant KRAS can safely and durably activate T cell responses in healthy people at high risk of developing pancreatic cancer, according to a phase 1 study.
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that develops from precursor lesions over an extended period of time. Currently, there are no interception methods available for the most common precursors, which are also challenging to detect through imaging. However, research suggests that immunologically based approaches may be effective, as the precursor microenvironment tends to be less immunosuppressive than the PDAC microenvironment.
One promising strategy involves blocking Netrin1, a protein that promotes liver metastasis of pancreatic cancer. This blockade has been shown to alleviate resistance to chemotherapy in pancreatic cancer patients. Additionally, targeting lipid metabolism pathways, specifically PIKfyve, has shown promise in overcoming resistance to treatment.
Evolutionary principles have been applied to understand tumor promotion in pancreatic cancer, providing new insights into potential therapeutic targets. Anti-progestin therapy has been explored as a means of targeting hallmarks of breast cancer risk, potentially offering benefits for pancreatic cancer patients as well. Furthermore, FBP1, a protein that controls liver cancer evolution from senescent MASH hepatocytes, is being investigated as a potential target for intervention.
Multicentre gene therapy trials for OTOF-related deafness are being followed up to assess long-term outcomes, which may have implications for other genetic disorders, including pancreatic cancer. Lastly, a prospective evaluation of genomics-guided off-label treatment is underway, demonstrating the importance of personalized medicine in tackling this devastating disease.
Written by urgent.news from Nature Medicine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
